Cochrane Abstracts
Artesunate versus quinine for treating severe malaria
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Artesunate Versus Quinine for Treating Severe Malaria." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433028/all/Artesunate_versus_quinine_for_treating_severe_malaria.
Artesunate versus quinine for treating severe malaria. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433028/all/Artesunate_versus_quinine_for_treating_severe_malaria. Accessed December 3, 2024.
Artesunate versus quinine for treating severe malaria. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433028/all/Artesunate_versus_quinine_for_treating_severe_malaria
Artesunate Versus Quinine for Treating Severe Malaria [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433028/all/Artesunate_versus_quinine_for_treating_severe_malaria.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Artesunate versus quinine for treating severe malaria
ID - 433028
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433028/all/Artesunate_versus_quinine_for_treating_severe_malaria
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
